Human eukaryotic release factor 3a depletion causes cell cycle arrest at G1 phase through inhibition of the mTOR pathway

Molecular and Cellular Biology

Volumn 27, Issue 16, 2007, Pages 5619-5629

  Chauvin, Céline ^a   Salhi, Samia ^a   Jean Jean, Olivier ^a,b  

^a CNRS   (France)

^b SORBONNE UNIVERSITÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EUKARYOTIC RELEASE FACTOR; EUKARYOTIC RELEASE FACTOR 3A; EUKARYOTIC RELEASE FACTOR 3B; GUANOSINE TRIPHOSPHATASE; INITIATION FACTOR; INITIATION FACTOR 4E BINDING PROTEIN 1; MAMMALIAN TARGET OF RAPAMYCIN; PROTEIN KINASE; S6 KINASE; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; COMPLEX FORMATION; CYTOSKELETON; ENZYME INHIBITION; ERF3A GENE; ERF3B GENE; EUKARYOTE; FLOW CYTOMETRY; GENE; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN DOMAIN; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; TRANSLATION REGULATION;

AMINO ACIDS; G1 PHASE; GENE SILENCING; GUANOSINE TRIPHOSPHATE; HCT116 CELLS; HUMANS; PEPTIDE TERMINATION FACTORS; PHOSPHORYLATION; POLYRIBOSOMES; PROTEIN BINDING; PROTEIN BIOSYNTHESIS; PROTEIN KINASES; PROTEIN STRUCTURE, TERTIARY; RNA, TRANSFER;

EUKARYOTA; MAMMALIA;

EID: 34547871617     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.00035-07     Document Type: Article

References (47)

1. Barbet, N. C., U. Schneider, S. B. Helliwell, I. Stansfield, M. F. Tuite, and M. N. Hall. 1996. TOR controls translation initiation and early G1 progression in yeast. Mol. Biol. Cell 7:25-42.
2. Basu, J., B. C. Williams, Z. Li, E. V. Williams, and M. L. Goldberg. 1998. Depletion of a Drosophila homolog of yeast Sup35p disrupts spindle assembly, chromosome segregation, and cytokinesis during male meiosis. Cell Motil. Cytoskeleton 39:286-302.
3. Borchsenius, A. S., A. A. Tchourikova, and S. G. Inge-Vechtomov. 2000. Recessive mutations in SUP35 and SUP45 genes coding for translation release factors affect chromosome stability in Saccharomyces cerevisiae. Curr. Genet. 37:285-291.
4. Brito, M., J. Malta-Vacas, B. Carmona, C. Aires, P. Costa, A. P. Martins, S. Ramos, A. R. Conde, and C. Monteiro. 2005. Polyglycine expansions in eRF3/GSPT1 are associated with gastric cancer susceptibility. Carcinogenesis 26:2046-2049.
5. Carnes, J., M. Jacobson, L. Leinwand, and M. Yarus. 2003. Stop codon suppression via inhibition of eRF1 expression. RNA 9:648-653.
6. Chauvin, C., S. Salhi, C. Le Goff, W. Viranaicken, D. Diop, and O. Jean-Jean. 2005. Involvement of human release factors eRF3a and eRF3b in translation termination and regulation of the termination complex formation. Mol. Cell. Biol. 25:5801-5811.
7. Chavatte, L., L. Frolova, L. Kisselev, and A. Favre. 2001. The polypeptide chain release factor eRF1 specifically contacts the s(4)UGA stop codon located in the A site of eukaryotic ribosomes. Eur. J. Biochem. 268:2896-2904.
8. Corradetti, M. N., and K. L. Guan. 2006. Upstream of the mammalian target of rapamycin: do all roads pass through mTOR? Oncogene 25:6347-6360.
9. Cosson, B., N. Berkova, A. Couturier, S. Chabelskaya, M. Philippe, and G. Zhouravleva. 2002. Poly(A)-binding protein and eRF3 are associated in vivo in human and Xenopus cells. Biol. Cell 94:205-216.
10. Cowley, S., H. Paterson, P. Kemp, and C. J. Marshall. 1994. Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells. Cell 77:841-852.
11. Diop, D., C. Chauvin, and O. Jean-Jean. 2007. Aminoglycosides and other factors promoting stop codon readthrough in human cells. C. R. Biol. 330:71-79.
12. Frolova, L., X. Le Goff, H. H. Rasmussen, S. Cheperegin, G. Drugeon, M. Kress, I. Arman, A. L. Haenni, J. E. Celis, M. Philippe, J. Justesen, and L. Kisselev. 1994. A highly conserved eukaryotic protein family possessing properties of polypeptide chain release factor. Nature 372:701-703.
13. Frolova, L., X. Le Goff, G. Zhouravleva, E. Davydova, M. Philippe, and L. Kisselev. 1996. Eukaryotic polypeptide chain release factor eRF3 is an eRF1- and ribosome-dependent guanosine triphosphatase. RNA 2:334-341.
14. Gielkens, A. L., T. J. Berns, and H. Bloemendal. 1971. An efficient procedure for the isolation of polyribosomes from tissue culture. Eur. J. Biochem. 22:478-484.
15. Hanic-Joyce, P. J., G. C. Johnston, and R. A. Singer. 1987. Regulated arrest of cell proliferation mediated by yeast prt1 mutations. Exp. Cell Res. 172:134-145.
16. Hauryliuk, V., A. Zavialov, L. Kisselev, and M. Ehrenberg. 2006. Class-1 release factor eRF1 promotes GTP binding by class-2 release factor eRF3. Biochimie 88:747-757.
17. Hay, N., and N. Sonenberg. 2004. Upstream and downstream of mTOR. Genes Dev. 18:1926-1945.
18. Horrevoets, A. J., R. D. Fontijn, A. J. van Zonneveld, C. J. de Vries, J. W. ten Cate, and H. Pannekoek. 1999. Vascular endothelial genes that are responsive to tumor necrosis factor-alpha in vitro are expressed in atherosclerotic lesions, including inhibitor of apoptosis protein-1, stannin, and two novel genes. Blood 93:3418-3431.
19. Hoshino, S., M. Imai, T. Kobayashi, N. Uchida, and T. Katada. 1999. The eukaryotic polypeptide chain releasing factor (eRF3/GSPT) carrying the translation termination signal to the 3′-poly(A) tail of mRNA. Direct association of eRF3/GSPT with polyadenylate-binding protein. J. Biol. Chem. 274:16677-16680.
20. Hoshino, S., M. Imai, M. Mizutani, Y. Kikuchi, F. Hanaoka, M. Ui, and T. Katada. 1998. Molecular cloning of a novel member of the eukaryotic polypeptide chain-releasing factors (eRF). Its identification as eRF3 interacting with eRF1. J. Biol. Chem. 273:22254-22259.
21. Hoshino, S., H. Miyazawa, T. Enomoto, F. Hanaoka, Y. Kikuchi, A. Kikuchi, and M. Ui. 1989. A human homologue of the yeast GST1 gene codes for a GTP-binding protein and is expressed in a proliferation-dependent manner in mammalian cells. EMBO J. 8:3807-3814.
22. Hosoda, N., T. Kobayashi, N. Uchida, Y. Funakoshi, Y. Kikuchi, S. Hoshino, and T. Katada. 2003. Translation termination factor eRF3 mediates mRNA decay through the regulation of deadenylation. J. Biol. Chem. 278:38287-38291.
23. Jakobsen, C. G., T. M. Segaard, O. Jean-Jean, L. Frolova, and J. Justesen. 2001. Identification of a novel termination release factor eRF3b expressing the eRF3 activity in vitro and in vivo. Mol. Biol. (Moscow) 35:672-681.
24. Janzen, D. M., and A. P. Geballe. 2004. The effect of eukaryotic release factor depletion on translation termination in human cell lines. Nucleic Acids Res. 32:4491-4502.
25. Kikuchi, Y., H. Shimatake, and A. Kikuchi. 1988. A yeast gene required for the G1-to-S transition encodes a protein containing an A-kinase target site and GTPase domain. EMBO J. 7:1175-1182.
26. Kobayashi, T., Y. Funakoshi, S. Hoshino, and T. Katada. 2004. The GTP-binding release factor eRF3 as a key mediator coupling translation termination to mRNA decay. J. Biol. Chem. 279:45693-45700.
27. Le Goff, X., M. Philippe, and O. Jean-Jean. 1997. Overexpression of human release factor 1 alone has an antisuppressor effect in human cells. Mol. Cell. Biol. 17:3164-3172.
28. Ma, L., Z. Chen, H. Erdjument-Bromage, P. Tempst, and P. P. Pandolfi. 2005. Phosphorylation and functional inactivation of TSC2 by Erk implications for tuberous sclerosis and cancer pathogenesis. Cell 121:179-193.
29. Malta-Vacas, J., C. Aires, P. Costa, A. R. Conde, S. Ramos, A. P. Martins, C. Monteiro, and M. Brito. 2005. Differential expression of the eukaryotic release factor 3 (eRF3/GSPT1) according to gastric cancer histological types. J. Clin. Pathol. 58:621-625.
30. Malumbres, M., and M. Barbacid. 2005. Mammalian cyclin-dependent kinases. Trends Biochem. Sci. 30:630-641.
31. Maquat, L. E. 2005. Nonsense-mediated mRNA decay in mammals. J. Cell Sci. 118:1773-1776.
32. Morley, S. J., and S. Naegele. 2002. Phosphorylation of eukaryotic initiation factor (eIF) 4E is not required for de novo protein synthesis following recovery from hypertonic stress in human kidney cells. J. Biol. Chem. 277:32855-32859.
33. Patino, M. M., J. J. Liu, J. R. Glover, and S. Lindquist. 1996. Support for the prion hypothesis for inheritance of a phenotypic trait in yeast. Science 273:622-626.
34. Paushkin, S. V., V. V. Kushnirov, V. N. Smirnov, and M. D. Ter-Avanesyan. 1996. Propagation of the yeast prion-like [psi+] determinant is mediated by oligomerization of the SUP35-encoded polypeptide chain release factor. EMBO J. 15:3127-3134.
35. Petsch, K. A., J. Mylne, and J. R. Botella. 2005. Cosuppression of eukaryotic release factor 1-1 in Arabidopsis affects cell elongation and radial cell division. Plant Physiol. 139:115-126.
36. Phillips-Jones, M. K., F. J. Watson, and R. Martin. 1993. The 3′ codon context effect on UAG suppressor tRNA is different in Escherichia coli and human cells. J. Mol. Biol. 233:1-6.
37. Pisareva, V. P., A. V. Pisarev, C. U. Hellen, M. V. Rodnina, and T. V. Pestova. 2006. Kinetic analysis of interaction of eukaryotic release factor 3 with guanine nucleotides. J. Biol. Chem. 281:40224-40235.
38. Pyronnet, S., and N. Sonenberg. 2001. Cell-cycle-dependent translational control. Curr. Opin. Genet. Dev. 11:13-18.
39. Roux, P. P., B. A. Ballif, R. Anjum, S. P. Gygi, and J. Blenis. 2004. Tumor-promoting phorbol esters and activated Ras inactivate the tuberous sclerosis tumor suppressor complex via p90 ribosomal S6 kinase. Proc. Natl. Acad. Sci. USA 101:13489-13494.
40. Salas-Marco, J., and D. M. Bedwell. 2004. GTP hydrolysis by eRF3 facilitates stop codon decoding during eukaryotic translation termination. Mol. Cell. Biol. 24:7769-7778.
41. Sarbassov, D. D., D. A. Guertin, S. M. Ali, and D. M. Sabatini. 2005. Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 307:1098-1101.
42. Stephens, L., K. Anderson, D. Stokoe, H. Erdjument-Bromage, G. F. Painter, A. B. Holmes, P. R. Gaffney, C. B. Reese, F. McCormick, P. Tempst, J. Coadwell, and P. T. Hawkins. 1998. Protein kinase B kinases that mediate phosphatidylinositol 3,4,5-trisphosphate-dependent activation of protein kinase B. Science 279:710-714.
43. Tallheden, T., C. Karlsson, A. Brunner, J. Van Der Lee, R. Hagg, R. Tommasini, and A. Lindahl. 2004. Gene expression during redifferentiation of human articular chondrocytes. Osteoarthritis Cartilage 12:525-535.
44. Tikhomirova, V. L., and S. G. Inge-Vechtomov. 1996. Sensitivity of sup35 and sup45 suppressor mutants in Saccharomyces cerevisiae to the anti-microtubule drug benomyl. Curr. Genet. 30:44-49.
45. Uchida, N., S. Hoshino, H. Imataka, N. Sonenberg, and T. Katada. 2002. A novel role of the mammalian GSPT/eRF3 associating with poly(A)-binding protein in Cap/poly(A)-dependent translation. J. Biol. Chem. 277:50286-50292.
46. Valouev, I. A., V. V. Kushnirov, and M. D. Ter-Avanesyan. 2002. Yeast polypeptide chain release factors eRF1 and eRF3 are involved in cytoskeleton organization and cell cycle regulation. Cell Motil. Cytoskeleton 52:161-173.
47. Zhouravleva, G., L. Frolova, X. Le Goff, R. Le Guellec, S. Inge-Vechtomov, L. Kisselev, and M. Philippe. 1995. Termination of translation in eukaryotes is governed by two interacting polypeptide chain release factors, eRF1 and eRF3. EMBO J. 14:4065-4072.